ELI LILLY & CO (LLY)
Clinical trial NCT06148272 updates: 1. completion date: 2026-09-01 → 2026-08-01 2. primary completion date: 2026-09-01 → 2026-08-01
Clinical trial NCT06148272 updates: 1. completion date: 2026-09-01 → 2026-08-01 2. primary completion date: 2026-09-01 → 2026-08-01
📉 **NEGATIVE** • Medium confidence analysis (69%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (20%) **Content type:** Clinical